The mice...10 May 2020 23:05
Are just like any other service goods, Hemo have created them and for that, they receive a fee from companies wishing to use them in their trials. They will never reap the benifits if one of these companies comes up with a saleable product, the best they can hope for is a possible royalty percentage, but this will be nothing compared to what the developing company will receive.